HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120

被引：0
|
作者：
JM Kovacs
JP Nkolola
H Peng
A Cheung
J Perry
CA Miller
MS Seaman
D Barouch
B Chen
机构：
[1] Harvard Medical School and Children's Hospital Boston,
[2] Beth Israel Deaconess Medical Center and Ragon Institute,undefined
[3] Children's Hospital Boston,undefined
[4] Beth Israel Deaconess Medical Center,undefined
来源：
Retrovirology | / 9卷
关键词：
Surface Plasmon Resonance; Neutralize Antibody Response; Surface Plasmon Resonance Analysis; Transfected 293T Cell; Elicit Neutralize Antibody;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120
    Kovacs, J. M.
    Nkolola, J. P.
    Peng, H.
    Cheung, A.
    Perry, J.
    Miller, C. A.
    Seaman, M. S.
    Barouch, D.
    Chen, B.
    RETROVIROLOGY, 2012, 9
  • [2] HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120
    Kovacs, James M.
    Nkolola, Joseph P.
    Peng, Hanqin
    Cheung, Ann
    Perry, James
    Miller, Caroline A.
    Seaman, Michael S.
    Barouch, Dan H.
    Chen, Bing
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (30) : 12111 - 12116
  • [3] The use of immune complex vaccines to enhance antibody responses against neutralizing epitopes on HIV-1 envelope gp120
    Hioe, Catarina E.
    Visciano, Maria Luisa
    Kumar, Rajnish
    Liu, Jianping
    Mack, Ethan A.
    Simon, Rachel E.
    Levy, David N.
    Tuen, Michael
    VACCINE, 2009, 28 (02) : 352 - 360
  • [4] HIV-1 envelope trimer has similar binding characteristics for carbohydrate-binding agents as monomeric gp120
    Hoorelbeke, Bart
    van Montfort, Thijs
    Xue, Jie
    LiWang, Patricia J.
    Tanaka, Haruo
    Igarashi, Yasuhiro
    Van Damme, Els J. M.
    Sanders, Rogier W.
    Balzarini, Jan
    FEBS LETTERS, 2013, 587 (07): : 860 - 866
  • [5] Vaccine with bacterium-like particles displaying HIV-1 gp120 trimer elicits specific mucosal responses and neutralizing antibodies in rhesus macaques
    Wang, Huaiyu
    Li, Pingchao
    Zhang, Mo
    Bi, Jinpeng
    He, Yizi
    Li, Fangshen
    Yu, Rongzhen
    Gao, Feng
    Kong, Wei
    Yu, Bin
    Chen, Ling
    Yu, Xianghui
    MICROBIAL BIOTECHNOLOGY, 2022, 15 (07): : 2022 - 2039
  • [6] GP120: Target for neutralizing HIV-1 antibodies
    Pantophlet, Ralph
    Burton, Dennis R.
    ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 : 739 - 769
  • [7] Conformation of the HIV-1 gp120 envelope glycoprotein
    Sodroski, J
    Wyatt, R
    Olshevsky, U
    Olshevsky, V
    Moore, J
    DEVELOPMENT AND APPLICATIONS OF VACCINES AND GENE THERAPY IN AIDS, 1996, 48 : 184 - 187
  • [8] AN IMPROVED METHOD FOR ASSESSING ANTIBODY-RESPONSES TO THE PRINCIPAL NEUTRALIZING DETERMINANT (PND) OF HIV-1 GP120
    SAKAMOTO, D
    BAENZIGER, J
    SINANGIL, F
    LEE, D
    TURCK, C
    STEIMER, K
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 85 - 85
  • [9] Designed Cyclic Permutants of HIV-1 gp120: Implications for Envelope Trimer Structure and Immunogen Design
    Saha, Piyali
    Bhattacharyya, Sanchari
    Kesavardhana, Sannula
    Miranda, Edward Roshan
    Ali, P. Shaik Syed
    Sharma, Deepak
    Varadarajan, Raghavan
    BIOCHEMISTRY, 2012, 51 (09) : 1836 - 1847
  • [10] Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120
    Lekkerkerker, AN
    Ludwig, IS
    van Vliet, SJ
    van Kooyk, Y
    Geijtenbeek, TBH
    VIROLOGY, 2004, 329 (02) : 465 - 476
12345